Renee Barge
- Naam
- Dr. R.M.Y. Barge
- Telefoon
- +31 71 526 2267
- R.M.Y.Barge@umail.LeidenUniv.NL
- Faculteit Geneeskunde
- Divisie 2
- Hematologie
- Hematologie algemeen
- van Kempen-Harteveld ML, Brand R, Kal HB, Verdonck LF, Hofman P, Schattenberg AV, van der Maazen RW, Cornelissen JJ, Eijkenboom WMH, van der Lelie JP, Oldenburger F, Barge RM, van Biezen A, Vossen JMJJ, Noordijk EM & Struikmans H (2008), Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers, International Journal of Radiation Oncology - Biology - Physics 71(5).
- Borne PAVD, Starrenburg CW, Barge RM, Marijt EW, Falkenburg JHF & Willemze R (2008), Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen, Bone Marrow Transplantation 42(2).
- van Rooden CJ, Schippers EF, Guiot HFL, Barge RM, Hovens MMC, van der Meer FJM, Rosendaal FR & Huisman MV (2008), Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: A Randomized double-blind controlled trial in patients with Hematologic malignancies, Journal of Clinical Oncology 26(3).
- Hoogendoorn M, Jedema I, Barge RMY, van Luxemburg SAP, Beaumont HF, Marijt EWA, Willemze R & Falkenburg JHF (2007), Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning, Leukemia 21(12).
- de Vries JF, von dem Borne PA, van Luxemburg-Heijs SAP, Heemskerk MHM, Willemze R, Falkenburg JHF & Barge RMY (2007), Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing, Haematologica 92(12).
- Kalpoe JS, van der Heiden PLJ, Vaessen N, Claas ECJ, Barge RM & Kroes ACM (2007), Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning, Bone Marrow Transplantation 40(2).
- Kalpoe JS, van der Heiden PLJ, Barge RMY, Houtzager S, Lankester AC, van Tol MJD & Kroes ACM (2007), Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning, European Journal of Haematology 78(4).
- ten Hove WR, Verspaget HW, Barge R, Lamers CB & van Hoek B (2007), Liver chimerism after allogeneic blood stem cell transplantation, Transplantation Proceedings 39(1).
- de Vries JF, Wammes LJ, Jedema I, van Dreunen L, Nijmeijer BA, Heemskerk MHM, Willemze R, Falkenburg JHF & Barge RMY (2007), Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria, Apoptosis 12(1).
- von dem Borne PA, Beaumont F, Starrenburg CWJI, Oudshoorn M, Hale G, Falkenburg JHF, Fibbe WE, Willemze R & Barge RMY (2006), Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab, Haematologica 91(11).
- Kerkhoffs JLH, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ & Brand A (2006), A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma, Blood 108(9).
- Martino, R.; Iacobelli, S.; Brand, R.; Jansen, T.; Biezen, A. van; Finke, J.; Bacigalupo, A.; Beelen, D.; Reiffers, J.; Devergie, A.; Alessandrino, E.; Mufti, G.J.; Barge, R.; Sierra, J.; Ruutu, T.; Boogaerts, M.; Falda, M.; Jouet, J.P.; Niederwieser, D.; Witte, T. de & Myelodysplastic Syndrome subcomm (2006), Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes, Blood 108(3).
- Kalpoe JS, Kroes ACM, Verkerk S, Claas ECJ, Barge RMY & Beersma MFC (2006), Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation, Bone Marrow Transplantation 38(1).
- de Vries JF, Falkenburg JHF, Willemze R & Barge RMY (2006), The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells, Haematologica 91(7).
- Barge RMY, Starrenburg CWJ, Falkenburg JHF, Fibbe WE, Marijt EW & Willemze R (2006), Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T-cell depletion: the Leiden experience, Bone Marrow Transplantation 37(12).
- van der Heiden PLJ, Jedema I, Willemze R & Barge RMY (2006), Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia, European Journal of Haematology 76(5).
- van der Heiden PLJ, Kalpoe JS, Barge RM, Willemze R, Kroes ACM & Schippers EF (2006), Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients, Bone Marrow Transplantation 37(7).
- Goselink HM, Hiemstra PS, Van Noort P, Barge RMY, Willemze R & Falkenburg JHF (2006), Cytokine-dependent proliferation of human CD34(+) progenitor cells in the absence of serum is suppressed by their progeny's production of serine proteinases, STEM CELLS 24(2).
- van Oosterhout M, Verburg RJ, Levarht EWN, Moolenburgh JD, Barge RM, Fibbe WE & van Laar JM (2005), High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities, Annals of the Rheumatic Diseases 64(12).
- van der Straaten HM, van Biezen A, Brand R, Schattenberg AVMB, Egeler RM, Barge RM, Cornelissen JJ, Schouten HC, Ossenkoppele GJ & Verdonck LF (2005), Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities, Haematologica 90(10).
- Kalpoe JS, van Dehn CE, Bollemeijer JG, Vaessen N, Claas ECJ, Barge RM, Willemze R, Kroes ACM & Beersma MFC (2005), Varicella zoster virus (VZV)-related progressive outer retinal necrosis (PORN) after allogeneic stem cell transplantation, Bone Marrow Transplantation 36(5).
- Hoogendoorn M, Wolbers JO, Smit WM, Schaafsma MR, Jedema I, Barge RMY, Willemze R & Falkenburg JHF (2005), Primary allogeneic T-Cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation, Clinical Cancer Research 11(14).
- Heemskerk MBA, van Walraven SM, Cornelissen JJ, Barge RMY, Bredius RGM, Egeler RM, Lie JLWT, Revesz T, Sintnicolaas K, Wulffraat NM, Donker AE, Hoogerbrugge PM, van Rood JJ, Claas FHJ & Oudshoorn M (2005), How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!, Bone Marrow Transplantation 35(7).
- van Rooden CJ, Schippers EF, Barge RMY, Rosendaal FR, Guiot HFL, van der Meer FJM, Meinders AE & Huisman MV (2005), Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: A prospective study, Journal of Clinical Oncology 23(12).
- van Walraven SM, Heemskerk MBA, Lie JLWT, Barge RMY, Cornelissen JJ, Egeler RM, Verdonck LF, Wulffraat N & Oudshoorn M (2005), The importance of identifying a back-up donor for unrelated stem cell transplantation, Bone Marrow Transplantation 35(5).
- Hoogendoorn M, Wolbers JO, Smit WM, Schaafsma MR, Barge RMY, Willemze R & Falkenburg JHF (2004), Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy, Leukemia 18(7).
- Jedema I, van der Werff NM, Barge RMY, Willemze R & Falkenburg JHF (2004), New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population, Blood 103(7).
- Posthuma EFM, Marijt EWAF, Barge RMY, van Soest RA, Baas IO, Starrenburg CWJI, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R & Falkenburg JHF (2004), alpha-interferon with very-low-dose donor lymphocyte infusion for Hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable Graft-versus-Host disease, Biology of Blood and Marrow Transplantation 10(3).
- Jedema I, Barge RMY, Frankel AE, Willemze R & Falkenburg JHF (2004), Acute myeloid leukemia cells in G(0) phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins, Experimental Hematology 32(2).
- Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap AK, Barge R, Beverstock GC & Rosenberg C (2004), A novel t(6;l4)(q25 similar to q27;q32) in acute myelocytic leukemia involves the BCL11B gene, Cancer Genetics and Cytogenetics 149(1).
- Jedema I, Barge RMY, van der Velden VHJ, Nijmeijer BA, van Dongen JJM, Willemze R & Falkenburg JHF (2004), Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity, Leukemia 18(2).
- van Rooden CJ, Rosendaal FR, Barge RMY, van Oostayen JA, van der Meer FJM, Meinders AE & Huisman MV (2003), Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound, British Journal of Haematology 123(3).
- Barge RMY, Osanto S, Marijt WAFE, Starrenburg CWJI, Fibbe WE, Nortier JWRH, Falkenburg JHF & Willemze R (2003), Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors, Experimental Hematology 31(10).
- Jedema I, Barge RMY, Nijmeijer BA, Willemze R & Falkenburg JHF (2003), Recruitment of leukemic cells from G(0) phase of the cell cycle by interferons results in conversion of resistance to daunorubicin, Leukemia 17(10).
- Lokhorst HM, Segeren CM, Verdonck LF, van der Holt B, Raymakers R, van Oers MHJ, Barge RMY, Schouten HC, Westveer PHM, Steijaert MMC, Cornelissen JJ & Sonneveld P (2003), Partially T-Cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: A prospective evaluation of patients treated in the phase III study HOVON 24 MM, Journal of Clinical Oncology 21(9).
- Jedema I, Barge RMY, Willemze R & Falkenburg JHF (2003), High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G(1) phase of the cell cycle and can be increased by interferon treatment, Leukemia 17(3).
- Veuger MJT, Honders MW, Willemze R & Barge RMY (2002), Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia, European Journal of Haematology 69(3).
- Tichelli A, Socie G, Marsh J, Barge R, Frickhofen N, McCann S, Bacigalupo A, Hows J, Marin P, Nachbaur D, Symeonidis A, Passweg J & Schrezenmeier H (2002), Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression, Annals of Internal Medicine 137(3).
- Veuger MJT, Heemskerk MHM, Honders MW, Willemze R & Barge RMY (2002), Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells, Blood 99(4).
- Brouwer RE, Hoefnagel J, van der Burg BB, Jedema I, Zwinderman KH, Starrenburg ICW, Kluin-Nelemans HC, Barge RMY, Willemze R & Falkenburg JHF (2001), Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis, British Journal of Haematology 115(2).
- Barge RMY, Brouwer RE, Beersma MFC, Starrenburg CWJ, Zwinderman AH, Hale G, Waldmann H, den Ottolander GJ, Falkenburg JHF, Willemze R & Fibbe WE (2001), Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome, Bone Marrow Transplantation 27(10).
- Verburg RJ, Kruize AA, van den Hoogen FHJ, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RMY, Bijlsma JWJ, van de Putte LB, Breedveld FC & van Laar JM (2001), High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy, Arthritis and Rheumatism 44(4).
- Veuger MJT, Honders MW, Landegent JE, Willemze R & Barge RMY (2000), A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells, Leukemia 14(9).
- Veuger MJT, Honders MW, Landegent JE, Willemze R & Barge RMY (2000), High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia, Blood 96(4).
- Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N, du Toit C, Abrahams L, Thomas V, Bunjes D, Duncker C, Wiesneth M, Selleslag D, Hidajat M, Starobinski M, Bird P & Waldmann H (2000), CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.